Novel Heterocyclic Compounds as Delta-5-Desaturase Inhibitors for Treating Metabolic and Cardiovascular Diseases
ACS Med Chem Lett
.
2021 Aug 2;12(8):1218-1219.
doi: 10.1021/acsmedchemlett.1c00394.
eCollection 2021 Aug 12.
Author
Ram W Sabnis
1
Affiliation
1
Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID:
34413950
PMCID:
PMC8366020
DOI:
10.1021/acsmedchemlett.1c00394
No abstract available
Publication types
Editorial